Basheer Elsolh, MD MPH FRCSC
NPI 1558045369ActiveIndividual· Surgery, Surgical Oncology· Daytona Beach, FL
Surgery, Surgical Oncology (MD MPH FRCSC) in Daytona Beach, Florida, trained at Queen's School of Medicine (class of 2017). Part D covered 99 prescriptions written in 2024, 89% of them generic. Merck Sharp & Dohme LLC was the largest of 6 companies reporting payments in 2025, $166.36 in all, mostly food and beverage.
Overview
| NPI | 1558045369 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD MPH FRCSC |
| Sole proprietor | No |
| NPI issued | Jun 12, 2023 |
| Last updated in NPPES | Dec 22, 2025 |
| Certified by provider | Dec 22, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Surgery, Surgical Oncology Primary | 2086X0206X | ME171420 | FL |
| Surgery | 208600000X | ME171420 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Surgical Oncology (FL) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 99 · 105 30-day fills |
|---|---|
| Patients | 59 |
| Total drug cost | $21,806 |
| Generic share | 89% of claims |
Education and affiliations
| Medical school | Queen's School of Medicine |
|---|---|
| Graduation year | 2017 |
| Medicare specialty | Surgical Oncology |
Medical group
- Florida Clinical Practice Association IncGainesville, FL · 1,924 clinicians
Hospital affiliation
- Halifax Health Medical CenterDaytona Beach, FL
Industry payments (Open Payments)
- 2025$166.36 · 8 payments from 6 companies
- 2024$97.26 · 4 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $37.28 | 2 |
| Recordati_rare_diseases_inc. | $35.55 | 2 |
| Lilly USA, LLC | $32.04 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.03 | 1 |
| Incyte Corporation | $21.47 | 1 |
What the 2025 payments were for
- Food and Beverage$166.36 · 8 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records